Skip to main content

Parkinson's Disease

Featured Article
"The availability of this new apomorphine sublingual formulation, along with an inhaled formulation under development, will broaden the treatment options for off periods," says Angelo Antonini, MD,…
Researchers found that some people lose their ability to swim when their Parkinson disease is treated with deep brain stimulation.

Insights

This retrospective database analysis evaluated the demographic, functional, and clinical characteristics of nursing facility residents (NFR) with Parkinson disease (PD) compared with those with PD psychosis.
Despite Parkinson disease diagnosis challenges, new research shines light on a potential noninvasive diagnostic test. Professor of neurology at the Brain Research Institute Gal Bitan, PhD, discusses his recent study findings.
Rob di Bie, MD, PhD, neurologist and professor of Movement Disorders at the University of Amsterdam’s Faculty of Medicine, discusses the long-term effects of a specific PD medication and the impact of starting the drug early.

Interactive Features

Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why these…
Back to Top